500 related articles for article (PubMed ID: 10947809)
21. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
[TBL] [Abstract][Full Text] [Related]
22. GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors.
Mannoury la Cour C; Hanoun N; Melfort M; Hen R; Lesch KP; Hamon M; Lanfumey L
J Neurochem; 2004 May; 89(4):886-96. PubMed ID: 15140188
[TBL] [Abstract][Full Text] [Related]
23. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
Gobbi G; Murphy DL; Lesch K; Blier P
J Pharmacol Exp Ther; 2001 Mar; 296(3):987-95. PubMed ID: 11181933
[TBL] [Abstract][Full Text] [Related]
24. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
[TBL] [Abstract][Full Text] [Related]
25. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
26. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
[TBL] [Abstract][Full Text] [Related]
27. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
[TBL] [Abstract][Full Text] [Related]
28. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine.
Le Poul E; Boni C; Hanoun N; Laporte AM; Laaris N; Chauveau J; Hamon M; Lanfumey L
Neuropharmacology; 2000; 39(1):110-22. PubMed ID: 10665824
[TBL] [Abstract][Full Text] [Related]
29. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain.
Adell A; Celada P; Artigas F
J Neurochem; 2001 Oct; 79(1):172-82. PubMed ID: 11595769
[TBL] [Abstract][Full Text] [Related]
30. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
31. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
Dupuis DS; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
33. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.
Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM
Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501
[TBL] [Abstract][Full Text] [Related]
34. Humanization of mouse 5-hydroxytryptamine1B receptor gene by homologous recombination: in vitro and in vivo characterization.
Bonaventure P; Umans L; Bakker MH; Cras P; Langlois X; Luyten WH; Megens AA; Serneels L; Van Leuven F; Leysen JE
Mol Pharmacol; 1999 Jul; 56(1):54-67. PubMed ID: 10385684
[TBL] [Abstract][Full Text] [Related]
35. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
36. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
[TBL] [Abstract][Full Text] [Related]
37. Decreased G-protein coupling of serotonin 5-HT(1A) receptors in the brain of 5-HT(1B) knockout mouse.
Ase AR; Sénécal J; Reader TA; Hen R; Descarries L
Neuropharmacology; 2002 Jun; 42(7):941-9. PubMed ID: 12069904
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor.
Hansen HH; Mikkelsen JD
Eur J Pharmacol; 1998 Jul; 352(2-3):307-15. PubMed ID: 9716368
[TBL] [Abstract][Full Text] [Related]
39. The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats.
Gur E; Newman ME; Avraham Y; Dremencov E; Berry EM
Nutr Neurosci; 2003 Jun; 6(3):169-75. PubMed ID: 12793521
[TBL] [Abstract][Full Text] [Related]
40. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Doménech T; Beleta J; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
